Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2017

01-09-2017 | Editorial

NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?

Authors: Ling Liu, Xuhang Li

Published in: Digestive Diseases and Sciences | Issue 9/2017

Login to get access

Excerpt

Inflammasomes are large multimeric protein complexes (Fig. 1) that actively regulate cellular immunity and homeostasis through sensing and responding to either intracellular or extracellular stimuli [1, 2]. They are grouped on the basis of their sensor proteins, including nucleotide-binding domain (NBD) and leucine-rich repeat (LRR)-containing receptors (NLRs), absent in melanoma-2 receptor (AIM2), and pyrin (Fig. 1a). The NLR family of intracellular innate immune receptors has more than 20 known members, including NLRP1, NLRP3, NLRP6, NLRP12, and NLRC4. The NLR family has two subfamilies, NLRP and NLRC, based on their N-terminal domains: NLRP contains a pyrin domain (PYD), whereas NLRC contains a caspase activation and recruitment domain (CARD) domain (Fig. 1a, b). Homotypic interactions between the pyrin domain of NLRP3 and the adaptor molecule apoptosis-associated spec-like protein containing CARD (ASC) bridge the association of caspase-1 to NLRP3 in a large protein complex termed the NLRP3 inflammasome (Fig. 1b). The NLRP3 inflammasome is one of the most studied subfamily members of inflammasomes, sensing and activated by a sizeable spectrum of pathogen-associated patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Little is known about the negative regulator of the NLRP3 inflammasome, except that a recent report has suggested interleukin (IL)-10 functions as a potent suppressor in cultured macrophages and in mice [3]. Activated caspase-1 converts the cytosolic precursors of proinflammatory cytokine IL-1β or IL-18 into biologically active forms (Fig. 1c), which substantially contribute to the pathogenesis of several autoinflammatory diseases, including Muckle–Wells syndrome, familial cold autoinflammatory syndrome, chronic infantile neurological cutaneous and articular (CINCA) syndrome, gouty arthritis, Alzheimer’s disease, silicosis, and alcoholic liver disease.
Literature
1.
3.
go back to reference Liu L, Dong Y, Ye M, et al. The pathogenic role of nlrp3 inflammasome activation in inflammatory bowel diseases of both mice and humans. J Crohns Colitis. 2017;11:737–750.PubMed Liu L, Dong Y, Ye M, et al. The pathogenic role of nlrp3 inflammasome activation in inflammatory bowel diseases of both mice and humans. J Crohns Colitis. 2017;11:737–750.PubMed
5.
go back to reference Zaki MH, Boyd KL, Vogel P, et al. The nlrp3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379–391.CrossRefPubMedPubMedCentral Zaki MH, Boyd KL, Vogel P, et al. The nlrp3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379–391.CrossRefPubMedPubMedCentral
6.
go back to reference Allen IC, TeKippe EM, Woodford RM, et al. The nlrp3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207:1045–1056.CrossRefPubMedPubMedCentral Allen IC, TeKippe EM, Woodford RM, et al. The nlrp3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207:1045–1056.CrossRefPubMedPubMedCentral
7.
go back to reference Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (dss) is mediated by the nlrp3 inflammasome. Gut. 2010;59:1192–1199.CrossRefPubMed Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (dss) is mediated by the nlrp3 inflammasome. Gut. 2010;59:1192–1199.CrossRefPubMed
8.
go back to reference Itani S, Watanabe T, Nadatani Y, et al. Nlrp3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep. 2016;6:39075.CrossRefPubMedPubMedCentral Itani S, Watanabe T, Nadatani Y, et al. Nlrp3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep. 2016;6:39075.CrossRefPubMedPubMedCentral
9.
go back to reference Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol. 2014;7:1139–1150.CrossRefPubMedPubMedCentral Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol. 2014;7:1139–1150.CrossRefPubMedPubMedCentral
10.
go back to reference Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ et al. Activation of nlrp3 inflammasome in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-017-4609-8. Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ et al. Activation of nlrp3 inflammasome in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-017-4609-8.
11.
go back to reference Song-Zhao GX, Srinivasan N, Pott J, et al. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol. 2014;7:763–774.PubMed Song-Zhao GX, Srinivasan N, Pott J, et al. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol. 2014;7:763–774.PubMed
Metadata
Title
NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
Authors
Ling Liu
Xuhang Li
Publication date
01-09-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4650-7

Other articles of this Issue 9/2017

Digestive Diseases and Sciences 9/2017 Go to the issue